AU7930498A - Composition for controlling mood disorders in healthy individuals - Google Patents

Composition for controlling mood disorders in healthy individuals

Info

Publication number
AU7930498A
AU7930498A AU79304/98A AU7930498A AU7930498A AU 7930498 A AU7930498 A AU 7930498A AU 79304/98 A AU79304/98 A AU 79304/98A AU 7930498 A AU7930498 A AU 7930498A AU 7930498 A AU7930498 A AU 7930498A
Authority
AU
Australia
Prior art keywords
mood disorders
composition
healthy individuals
controlling mood
controlling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79304/98A
Other languages
English (en)
Inventor
Claudio Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau HealthScience SpA
Original Assignee
Sigma Tau HealthScience SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau HealthScience SpA filed Critical Sigma Tau HealthScience SpA
Publication of AU7930498A publication Critical patent/AU7930498A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
AU79304/98A 1997-06-18 1998-06-12 Composition for controlling mood disorders in healthy individuals Abandoned AU7930498A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM97A0365 1997-06-18
IT97RM000365A IT1291930B1 (it) 1997-06-18 1997-06-18 Composizione riequilibratrice delle turbe dell'umore in individui sani
PCT/IT1998/000157 WO1998057629A1 (en) 1997-06-18 1998-06-12 Composition for controlling mood disorders in healthy individuals

Publications (1)

Publication Number Publication Date
AU7930498A true AU7930498A (en) 1999-01-04

Family

ID=11405131

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79304/98A Abandoned AU7930498A (en) 1997-06-18 1998-06-12 Composition for controlling mood disorders in healthy individuals

Country Status (13)

Country Link
US (1) US6335021B1 (instruction)
EP (1) EP1001760B1 (instruction)
JP (1) JP2002505681A (instruction)
KR (1) KR20010013887A (instruction)
AT (1) ATE288265T1 (instruction)
AU (1) AU7930498A (instruction)
CA (1) CA2294589A1 (instruction)
DE (1) DE69828881T2 (instruction)
DK (1) DK1001760T3 (instruction)
ES (1) ES2236910T3 (instruction)
IT (1) IT1291930B1 (instruction)
PT (1) PT1001760E (instruction)
WO (1) WO1998057629A1 (instruction)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2806307B1 (fr) * 2000-03-20 2002-11-15 Mane Fils V Preparation parfumee solide sous forme de microbilles et utilisation de ladite preparation
IL157561A0 (en) * 2001-03-04 2004-03-28 Sterling Medivations Inc Infusion hub assembly and fluid line disconnect system
SK15862003A3 (sk) * 2001-05-29 2004-06-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Použitie alkanoyl L-karnitínu na prípravu liečiva na liečenie anhedónie
US7700074B2 (en) * 2002-02-07 2010-04-20 Pettegrew Jay W Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
US20050272812A1 (en) * 2002-02-07 2005-12-08 Pettegrew Jay W Methor for use of acetyl-L-carnitine (ALCAR) for treatment of depressive disorders in humans
US7407778B2 (en) * 2002-02-07 2008-08-05 Pettegrew Jay W Compounds, compositions and methods for treating neuropsychiatric disorders
US20040071681A1 (en) * 2002-10-10 2004-04-15 Lydia Muller Method and composition for reducing cravings for a craved substance
US20060257842A1 (en) * 2003-05-29 2006-11-16 Pettegrew Jay W Cryopreservation media and molecules
ATE437884T1 (de) * 2003-05-29 2009-08-15 Jay W Pettegrew Glycerophosphocholin und derivate davon zur medizinischen abbildung von neuropsychiatrischen erkrankungen
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
JP2006137746A (ja) * 2004-10-13 2006-06-01 Otsuka Pharmaceut Factory Inc オレキシン誘導組成物
US20070015495A1 (en) * 2005-07-15 2007-01-18 Agilis Systems, Inc. Mobile resource location-based customer contact methods
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US8340944B2 (en) * 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20080210748A1 (en) * 2005-11-30 2008-09-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware, Systems and methods for receiving pathogen related information and responding
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US8000981B2 (en) 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20070124219A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US7827042B2 (en) * 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US7927787B2 (en) * 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
MX2012014127A (es) 2010-06-16 2013-06-28 Sigma Tau Ind Farmaceuti Acetil-carnitina para uso en un metodo para incrementar neurogenesis en tejido nervioso.
IL298209A (en) 2020-05-15 2023-01-01 Alfasigma Spa Composition comprising methylfolate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0340759A1 (en) 1988-05-06 1989-11-08 MAGIS FARMACEUTICI S.p.A. Salts of O-mono (di)-acetyl-glycero-mono-(bis)-(di)-phosphates of L-acetyl-carnitine and of L-acetyl carnitine esters
JP3942207B2 (ja) 1995-02-17 2007-07-11 武田薬品工業株式会社 うつ性症状改善剤
US5977162A (en) * 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
US6066664A (en) * 1997-06-06 2000-05-23 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Method for decreasing the appetite in bulimic, overweight individuals

Also Published As

Publication number Publication date
JP2002505681A (ja) 2002-02-19
ITRM970365A0 (instruction) 1997-06-18
EP1001760A1 (en) 2000-05-24
IT1291930B1 (it) 1999-01-21
ATE288265T1 (de) 2005-02-15
ITRM970365A1 (it) 1998-12-18
KR20010013887A (ko) 2001-02-26
WO1998057629A1 (en) 1998-12-23
EP1001760B1 (en) 2005-02-02
DK1001760T3 (da) 2005-05-23
CA2294589A1 (en) 1998-12-23
PT1001760E (pt) 2005-04-29
DE69828881T2 (de) 2006-01-19
US6335021B1 (en) 2002-01-01
ES2236910T3 (es) 2005-07-16
DE69828881D1 (de) 2005-03-10

Similar Documents

Publication Publication Date Title
AU7930498A (en) Composition for controlling mood disorders in healthy individuals
IL121170A0 (en) Compositions for the treatment of dermatological disorders
EP0876391A4 (en) USE OF NEW STEROID ESTERS ACTING AGAINST SKIN CONDITIONS
EP0695758A3 (en) Human cancer inhibitory pentapeptide amides and esters
IL123162A0 (en) Pyridazin-3-one derivatives their use and intermediates for their production
AU2122995A (en) Inhibition of cataracts and other disorders
HUP0003381A3 (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders
EP0902665A4 (en) NUTRITIONAL PHYTO-ESTROGENES IN ESTRO-REPLACEMENT THERAPY
AU2158797A (en) Benzopyran derivatives having leukotriene-antagonistic action
AU2058697A (en) Treatment of sleep disorders
AU3745795A (en) Use of CCK-B receptor antagonists for the treatment of sleepdisorders
AU4674797A (en) Phenylalaninol derivatives for the treatment of central nervous system disorders
AU8156094A (en) Methods of inhibiting breast disorders
AU3461897A (en) Methods for producing sphingolipids and sphingolipid derivatives
AUPM922594A0 (en) Reduction of methane production in animals
SI9720060B (en) Use of 2-phenyl-1, 2-benzisoselenazol-3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease
AU6689698A (en) Methods for producing pure perlecan and other heparan sulfate proteoglycans
AU1540995A (en) Methods for the production of modified plants
MX9703810A (es) Medicamento que comprende un derivado de carnitinapara tratar la enfermedad de alzheimer en pacientes con inicio prematuro.
GB2291319B (en) Musical sound reproduction controller with two-stage adjustment of tone
CA2260863A1 (en) Treatment of psychotic disorders
AU3948395A (en) Synthesis of 6-azaandrostenones
IL129339A0 (en) New pentaerythrytol derivatives their production and use and intermediates for their synthesis
IL114300A0 (en) Improved methods for the determination and adjustment of prolacting daily rhythms
AU3618595A (en) Pyridonecarboxylic acid derivative and intermediate for the synthesis of the same